APA (7th ed.) Citation

R, D., RN, H., P, B., JM, M., & BJ, K. (2023). Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment". Human vaccines & immunotherapeutics, 19(1), 2195333. https://doi.org/10.1080/21645515.2023.2195333

Chicago Style (17th ed.) Citation

R, Das, Hyer RN, Burton P, Miller JM, and Kuter BJ. "Author Reply to "Heterologous MRNA-based COVID-19 Booster Strategies: Comment"." Human Vaccines & Immunotherapeutics 19, no. 1 (2023): 2195333. https://doi.org/10.1080/21645515.2023.2195333.

MLA (9th ed.) Citation

R, Das, et al. "Author Reply to "Heterologous MRNA-based COVID-19 Booster Strategies: Comment"." Human Vaccines & Immunotherapeutics, vol. 19, no. 1, 2023, p. 2195333, https://doi.org/10.1080/21645515.2023.2195333.